Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| Revenues | 50.3 | 14.9 | 28.8 | 60.2 | 9.6 | 10.6 | 11.9 | 11.3 |
| Revenue growth | 238.7% | -48.4% | -52.2% | 528.1% | -10.0% | -10.7% | 5.5% | |
| Cost of goods sold | 4.9 | 5.0 | 5.2 | 5.3 | 4.6 | 7.2 | 6.4 | 7.3 |
| Gross profit | 45.4 | 9.8 | 23.6 | 54.9 | 4.9 | 3.4 | 5.5 | 4.0 |
| Gross margin | 90.3% | 66.2% | 82.1% | 91.2% | 51.6% | 32.0% | 46.1% | 35.8% |
| Selling, general and administrative | 19.1 | 15.8 | 17.7 | 17.3 | 14.6 | 9.0 | 6.7 | 6.9 |
| Research and development | 25.5 | 33.9 | 31.9 | 32.4 | 18.2 | 4.1 | 5.5 | 1.8 |
| EBITA | 1.3 | -39.3 | -25.4 | 5.7 | -27.3 | -9.2 | -6.2 | -4.1 |
| EBITA margin | 2.7% | -264.6% | -88.4% | 9.4% | -285.0% | -86.3% | -51.8% | -36.3% |
| Amortization of intangibles | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| EBIT | 0.8 | -39.9 | -26.0 | 5.1 | -27.8 | -9.7 | -6.7 | -4.6 |
| EBIT margin | 1.6% | -268.2% | -90.3% | 8.5% | -290.5% | -91.3% | -56.2% | -41.0% |
| Pre-tax income | 1.1 | -39.6 | -25.9 | 5.3 | -27.8 | -9.8 | -6.7 | -4.6 |
| Income taxes | 0.0 | 0.0 | -0.2 | -0.2 | 0.5 | 0.0 | -2.7 | -2.0 |
| Tax rate | 0.1% | 0.0% | 0.7% | | | 0.0% | 39.7% | 44.0% |
| Net income | 1.1 | -39.6 | -25.7 | 5.5 | -28.2 | -9.8 | -5.8 | -4.2 |
| Net margin | 2.1% | -266.5% | -89.2% | 9.1% | -294.4% | -92.0% | -48.3% | -37.0% |
| |
| Diluted EPS | $0.03 | ($1.40) | ($1.09) | $0.23 | ($1.26) | ($1.04) | ($3.76) | ($2.84) |
| Shares outstanding (diluted) | 32.4 | 28.3 | 23.5 | 23.7 | 22.4 | 9.4 | 1.5 | 1.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|